Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BeiGene and Cancer Genetics Form Precision Medicine Collaboration

publication date: Dec 7, 2016
Beijing's BeiGene will collaborate with Cancer Genetics of New Jersey, a company that develops molecular markers and diagnostics to advance precision medicine in oncology. Cancer Genetics will provide central lab support for BeiGene's clinical trials. It will also identify patient populations that respond to BeiGene's four clinical-stage drug candidates, and it will suggest immunotherapies developed by other biopharmas that may complement BeiGene's own candidates in joint-drug regimens. More details....

Stock Symbols: (NSDQ: BGNE) (NSDQ: CGIX)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital